Macrophage Membrane‐Biomimetic Multi‐Layered Nanoparticles Targeting Synovial Angiogenesis for Osteoarthritis Therapy
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202401985 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Junyi Liao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. Hauptthemen laut MEDLINE: Osteoarthritis, Nanoparticles, Macrophages, Synovial Membrane. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chongqing Medical Scientific Research Project (Joint Project of Chongqing Health Commission and Science and Technology Bureau), Natural Science Foundation of Chongqing.
Abstract (Originalsprache)
Osteoarthritis (OA) is an inflammatory and progressive joint disease characterized by angiogenesis‐mediated sustained, chronic, and low‐grade synovitis. Anti‐angiogenesis is emerging as a strategy for attenuating OA progression, but is often compromised by poor targeted drug delivery and immune clearance. Recent studies have identified macrophages formed a “protective barrier” in the lining layer (LL) of synovium, which blocked the communication of joint cavity and sublining layer (SL) of synovium. Inspired by natural mimicry, macrophage membrane‐camouflaged drug delivery is explored to avoid immune clearance. Based on the single cell RNA sequencing, the CD34 + synovial cells are identified as “sentinel cells” for synovium angiogenesis. Consequently, CD34 antibody‐modified macrophage membrane is constructed to target new angiogenesis. Hence, a biomimetic multi‐layered nanoparticle (NP) is developed that incorporates axitinib‐loaded poly(lactic‐co‐glycolic) acid (PLGA) with CD34 antibody modified macrophage membrane (Atb@NP@Raw@CD34) to specifically deliver axitinib (Atb) to the SL and sustain inhibiting angiogenesis without immune elimination. It is found that the Atb@NP@Raw@CD34 can pass through macrophage “barrier”, specifically targeting CD34 + cells, continuously releasing Atb and anti‐angiogenesis in OA synovitis. Furthermore, in vivo data demonstrated that Atb@NP@Raw@CD34 can attenuate joint degeneration by inhibiting synovium angiogenesis‐mediated synovitis. In conclusion, local injection of Atb@NP@Raw@CD34 presents a promising approach for clinically impeding OA progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
- Chongqing Municipal Health Commission Key Laboratory of Musculoskeletal Regeneration and Translational Medicine, Orthopaedic Research Laboratory of Chongqing Medical University, Chongqing, 400016, China.
ORCID-Profile: Wei Huang
Förderung
- National Natural Science Foundation of China
- Chongqing Medical Scientific Research Project (Joint Project of Chongqing Health Commission and Science and Technology Bureau)
- Natural Science Foundation of Chongqing
- CQMU Program for Youth Innovation in Future Medicine
- Cultivating Program and Candidate of Tip-Top Talent of The First Affiliated Hospital of Chongqing Medical University
- Special support from Chongqing Postdoctoral Research Program
- China Postdoctoral Science Foundation
- Hong Kong Scholars Program
Zitieren
APA
Liao, J., Zhu, Z., Zou, J., Liu, S., Luo, X., Bao, W., Du, C., Lei, Y., & Huang, W. (2025). Macrophage Membrane‐Biomimetic Multi‐Layered Nanoparticles Targeting Synovial Angiogenesis for Osteoarthritis Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401985
Vancouver
Liao J, Zhu Z, Zou J, Liu S, Luo X, Bao W, et al. Macrophage Membrane‐Biomimetic Multi‐Layered Nanoparticles Targeting Synovial Angiogenesis for Osteoarthritis Therapy. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202401985
BibTeX
@article{Liao2025,
author = {Liao, Junyi and Zhu, Zhenglin and Zou, Jing and Liu, Senrui and Luo, Xuefeng and Bao, Wei and Du, Chengcheng and Lei, Yiting and Huang, Wei},
title = {Macrophage Membrane‐Biomimetic Multi‐Layered Nanoparticles Targeting Synovial Angiogenesis for Osteoarthritis Therapy},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202401985}
}
EUVIMED